Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests.
OBJECTIVE
To study cerebral abnormalities in myotonic dystrophy (MD) and determine the different patterns of cerebral function in patients with MD with maternal (mMD) vs paternal (pMD) inheritance.


METHODS
Patients with MD and normal controls were studied with neuropsychological testing, magnetic resonance imaging, and single photon emission computed tomography.


METHODS
Studies were done at Harbor-UCLA Medical Center, Torrance, Calif.


METHODS
Twenty-two consecutive-patients with MD, 11 of whom had pMD and eight mMD, and 10 normal controls were studied. Diagnoses were made on the basis of family history, electromyography, and clinical examinations. Normal subjects in the same age distribution were studied for comparisons.


RESULTS
We found significantly lower neuropsychological performance and cerebral blood flow in the patients with MD compared with the controls. Patients with mMD had statistically lower scores on IQ tests and more extensive cerebral hypoperfusion when compared with those with pMD. Changes in cerebral blood flow were most severe in the frontal and temporoparietal association cortex. Cerebral blood blow measures strongly correlated with IQ.


CONCLUSIONS
Patients with mMD had earlier onset of disease and lower IQs than the pMD group. The pattern of cerebral perfusion in the mMD group was consistent with a diffuse brain injury, while cerebral perfusion in pMD showed more minor changes. These findings emphasize the cognitive differences between mMD and pMD.
Chang
L
L
Department of Neurology, Harbor-UCLA Medical Center, Torrance 90509.
Anderson
T
T
Migneco
O A
OA
Boone
K
K
Mehringer
C M
CM
Villanueva-Meyer
J
J
Berman
N
N
Mena
I
I
D000293:Adolescent; D000328:Adult; D002560:Cerebrovascular Circulation; D002648:Child; D005260:Female; D006801:Humans; D007360:Intelligence; D008279:Magnetic Resonance Imaging; D008297:Male; D001523:Mental Disorders / Q000150:complications; D008875:Middle Aged; D009223:Myotonic Dystrophy / Q000000981:diagnostic imaging / Q000473:pathology* / Q000503:physiopathology / Q000523:psychology*; D009483:Neuropsychological Tests; D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon
D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime